We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Stay up to date on the topics that matter to you

Trending News

A close-up photo of a person's eyes.

Pupil Dilation Correlates With Improved Working Memory

An image showing the words "prime editing".

Probing the Inner World of Cells Provides Unexpected Boost to Prime Editing

Microscopic image of a group of bacteria cells

Phage Therapies for Multidrug-Resistant Infections Should Consider Host Response

Electron Videography Captures Microscopic Moving Dance in Cell Membranes

Machine Learning Reveals Sex Disparities in Heart Disease Diagnosis

Supercomputer Simulation Unveils New Insights Into Membrane Fusion

News

Earliest Marker for Autism Found in Young Infants

NIH-funded study finds attention to others’ eyes declines in 2 to 6-month-old infants later diagnosed with autism.

NIH-funded Study Finds that Gabapentin may Treat Alcohol Dependence

Promising results from a randomized, controlled clinical trial of the medication.

BBSRC Invests £10 M in Synthetic Biology

The investment has been allocated to the fund by the BBSRC in response to the 2012 Synthetic Biology Roadmap, which sets out plans to harness opportunities in this area.

Immunocore Achieves Research Milestone in GSK Collaboration

Under the agreement announced in July, Immunocore will receive up to £142 million in pre-clinical milestone payments across the targets.

Biocartis Announces Completion of EUR 30 Million Series E Equity Fundraising

Company poised for 2014 commercial launch.

ADC Therapeutics Licenses Proprietary Antibodies from Five Prime Therapeutics

Adds an additional proprietary ADC development program in oncology.

Repligen Completes Expansion of U.S. Manufacturing Facility

Waltham boost doubles chromatography capacity.

NeoStem Subsidiary PCT Announces Collaboration with ATMI

Xpansion system provides bioreactor expansion capability.

Altus Signs Agreement with Zogenix

D&O Agreement for development of abuse deterrent formulations of Zohydro™ ER.

Pfenex Awards a Contract to Paragon Bioservices

Contract for cGMP manufacturing of recombinant protective antigen, for phase 1 clinical trial of Company’s anthrax vaccine.

Advertisement

Advertisement

Decoratvive background images

Never miss a story

with the Breaking Science News daily newsletter